Orient Europharma Co

Orient Europharma Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Orient Europharma Co (4120.TWO) as of Oct 22, 2026 is -298.82 M TWD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 15.14 M TWD — a change of -2,073.85% (lower).

EBITDA

-298.82 MTWD

YoY

-2,073.85%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Orient Europharma Co is 2025 -298.82 M TWD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Orient Europharma Co was 2024 15.14 M TWD. It decreases by -2,073.85% lower compared to the previous year.

The Orient Europharma Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
357.19 M TWD
Jan 1, 2019
336.41 M TWD
Jan 1, 2020
117.36 M TWD
Jan 1, 2021
110.95 M TWD
Jan 1, 2022
-275.76 M TWD
Jan 1, 2023
75.04 M TWD
Jan 1, 2024
15.14 M TWD
Jan 1, 2025
-298.82 M TWD
The Orient Europharma Co EBITDA history
YEAREBITDAYoY
-298.82 MTWD-2,073.85%
15.14 MTWD-79.82%
75.04 MTWD-127.21%
-275.76 MTWD-348.55%
110.95 MTWD-5.46%
117.36 MTWD-65.12%
336.41 MTWD-5.82%
357.19 MTWD-17.97%
435.42 MTWD-3.42%
450.85 MTWD+71.07%
263.54 MTWD+23.47%
213.44 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Orient Europharma Co Stock analysis

What does Orient Europharma Co do? Orient Europharma Co Ltd manufactures and trades western medicine, health food, and cosmetics. The company operates in the nutritious healthcare products and medical cosmetic products segment, offering infant milk powders, nutritious products, and functional healthcare products. It also provides dermatological preparations, medical hair care series, organic skin care series, and medical make-up products. In the western drugs segment, the company supplies products for cardiovascular diseases, cancer, blood diseases, diabetes, central nervous system diseases, and asthma. The company's primary customers include consumers seeking healthcare solutions and beauty products. Its products are sold under the company's own brand, targeting health-conscious individuals and those requiring medical-grade skincare and pharmaceuticals. The firm's segments focus on delivering specialized products for specific health conditions and cosmetic needs. Orient Europharma Co Ltd generates revenue through the sale of its manufactured and traded products across multiple segments. The nutritious healthcare products segment contributes to sales of infant milk powders and functional healthcare items, while the medical cosmetic products segment drives sales of dermatological and organic skincare lines. The western drugs segment supports revenue through pharmaceuticals for chronic and acute medical conditions. Orient Europharma Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Orient Europharma Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Orient Europharma Co is -298.82 M TWD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Orient Europharma Co changed from 15.14 M TWD to -298.82 M TWD, representing a -2,073.85% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Orient Europharma Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Orient Europharma Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Orient Europharma Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Orient Europharma Co